|
Device | ESSURE SYSTEM FOR PERMANENT BIRTH CONTROL |
Generic Name | Transcervical contraceptive tubal occlusion device |
Regulation Number | 884.5380 |
Applicant | BAYER PHARMA AG MOLLERSTRABE 178 BERLIN 13353 |
PMA Number | P020014 |
Supplement Number | S041 |
Date Received | 03/14/2014 |
Decision Date | 06/29/2015 |
Product Code |
HHS |
Advisory Committee |
Obstetrics/Gynecology |
Clinical Trials | NCT01327105
|
Supplement Type | Normal 180 Day Track |
Supplement Reason | Labeling Change - Indications/instructions/shelf life/tradename |
Expedited Review Granted? | No |
Combination Product | No |
Approval Order Statement APPROVAL FOR CHANGING THE ESSURE INSTRUCTIONS FOR USE TO REPLACE THE PREVIOUSLY APPROVED MODIFIED HYSTEROSALPINGOGRAM CONFIRMATION TEST WITH THE TRANSVAGINAL ULTRASOUND/ HYSTEROSALPINGOGRAM CONFIRMATION TEST ALGORITH |
Post-Approval Study | Show Report Schedule and Study Progress |